Table 3. Sleep and fatigue scales in DM1 and DM2 patients compared with healthy controls at baseline and follow-up.
| Cut-off values | DM1 (n = 16) |
DM2 (n = 16) |
Control group (n = 17) | DM1 compared with controls |
DM2 compared with controls |
||
|---|---|---|---|---|---|---|---|
| PSQI total score | >5 | T1 |
5.2 ± 2.27 6/15 (40.0%) |
6.40 ± 3.62 8/15 (53.3%) |
3.00 ± 2.07 1/16 (6.3%) |
7.97 (1.014) p = 0.009 |
10.48 (1.282) p = 0.003 |
| T2 |
5.87 ± 3.07 6/16 (37.5%) |
5.31 ± 4.08 8/16 (50.0%) |
2.53 ± 2.42 2/17 (11.8%) |
12.12 (1.213) p = 0.002 |
5.76 (0.835) p = 0.023 |
||
| KFSS | >3.7 | T1 |
4.05 ± 1.73 9/16 (56.3%) |
4.49 ± 1.71 11/16 (68.8%) |
2.26 ± 0.79 0/16 (0%) |
14.08 (1.361) p = 0.001 |
22.33 (1.674) p < 0.001 |
| T2 |
4.30 ± 1.46 11/16 (68.8%) |
4.25 ± 1.66 9/16 (56.3%) |
1.94 ± 0.92 2/17 (11.8%) |
31.13 (1.948) p < 0.001 |
24.61 (1.736) p < 0.001 |
||
| DSS | >10 | T1 |
10.63 ± 3.07 8/16 (50.0%) |
8.00 ± 4.62 6/16 (37.5%) |
7.06 ± 3.17 3/16 (18.8%) |
10.41 (1.144) p = 0.003 |
0.45 (0.237) |
| T2 |
12.25 ± 5.13 8/16 (50.0%) |
8.06 ± 4.06 4/16 (25.5%) |
6.00 ± 4.26 1/16 (6.3%) |
14.06 (1.326) p = 0.001 |
1.97 (0.495) | ||
| ESS | >10 | T1 | 9.00 ± 3.25 6/16 (37.5%) |
7.19 ± 3.76 2/16(12.5%) |
6.27 ± 3.08 2/15 (13.3%) |
5.77 (0.861) p = 0.023 |
0.55 (0.267) |
| T2 |
10.62 ± 4.19 9/16 (56.3%) |
6.75 ± 3.53 2/16(12.5%) |
5.76 ± 3.05 1/17 (5.9%) |
14.62 (1.326) p = 0.001 |
0.74 (0.338) | ||
| UNS | >13 | T1 | 8.94 ± 3.71 2/16 (12.5%) |
5.31 ± 2.41 0/16 (0%) |
6.00 ± 2.19 0/16 (0%) |
7.42 (0.965) p = 0.011 |
0.71 (0.3) |
| T2 | 9.94 ± 5.58 4/16 (25.0%) |
6.44 ± 2.76 0/16 (0%) |
5.82 ± 2.65 0/17 (0%) |
7.46 (0.953) p = 0.010 |
0.43 (0.229) |
Score values of sleep and fatigue scales at baseline (T1) and follow-up (T2), mean ± SD are given in columns 4 to 6. Mean values that score above the clinical cut-off of pathological performing are indicated in bold. Numbers of participants with scores above the clinical cut-off of pathological performing (percentages of patients scoring above cut-off values) are also given in columns 4 to 6, and lower n due to missing values are indicated. Results of group comparisons are given in columns 7 to 8 (F-values; significant differences, p < 0.05, are indicated in bold). Cohen´s d-values for the effect sizes are given in brackets.